| Literature DB >> 31489927 |
Vera Balan1, Cosmin-Teodor Mihai2, Florina-Daniela Cojocaru3, Cristina-Mariana Uritu4, Gianina Dodi5, Doru Botezat6, Ioannis Gardikiotis7.
Abstract
In the last two decades, Fourier Transform Infrared (FTIR) and Raman spectroscopies turn out to be valuable tools, capable of providing fingerprint-type information on the composition and structural conformation of specific molecular species. Vibrational spectroscopy's multiple features, namely highly sensitive to changes at the molecular level, noninvasive, nondestructive, reagent-free, and waste-free analysis, illustrate the potential in biomedical field. In light of this, the current work features recent data and major trends in spectroscopic analyses going from in vivo measurements up to ex vivo extracted and processed materials. The ability to offer insights into the structural variations underpinning pathogenesis of diseases could provide a platform for disease diagnosis and therapy effectiveness evaluation as a future standard clinical tool.Entities:
Keywords: Raman spectroscopy; clinic; ex vivo; fingerprint; fourier transform infrared spectroscopy; in vivo
Year: 2019 PMID: 31489927 PMCID: PMC6766044 DOI: 10.3390/ma12182884
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Infrared multi-range options.
Figure 2(A) Guar gum chemical formula; (B) FTIR-ATR spectrum of dried sample guar gum analysed using a Nexus FTIR Diamond instrument (Thermo Scientific) with a Smart Orbit diamond crystal ATR accessory in the range of 400–4000 cm−1.
Figure 3Strategy in biomedical applications.
Typical Raman and FTIR band allocations in atherosclerosis plaque.
| Raman Peak, cm−1 | Assignment | Observations | FTIR Peak, cm−1 | Assignment | Observations |
|---|---|---|---|---|---|
| 2885, 1674 | C–H stretching and bending | Cholesteryl esters and cholesterol [ | 3500, 3100 | Amide A, B | Proteins [ |
| 1740 | C=O stretching | 3005 | Unsaturated aliphatic compounds | Cholesteryl oleate and linoleate [ | |
| 1443 | C=C stretching | 2800–3000 | CH2/CH3 | Higher absorbance for lipids than for proteins [ | |
| 704 | Vibration of steroid rings | 1710–1750 | C=O stretching | Lipids [ | |
| 1660, 1244 | Amide I, III | Proteins [ | 1730 | C=O | Marker for lipids, cholesteryl esters and triglycerides [ |
| 1004 | Phenylalanine | 1718–1487 | Alterations of the protein’s secondary structure [ | ||
| 1580, 1130, 750 | Heme | Hb [ | 1652, 1539, 1236 | Amide II and III | Proteins [ |
| 1070–1080 | Phosphate stretching | Hydroxyapatite [ | |||
| 964 | Stretching vibrations of ν(PO4) | Calcification [ | 1080–1100 and 600 | Hydroxyapatite [ | |
| 1058 | C–O | Cholesterol alone [ | |||
Raman wavenumbers of diabetic Sprague Dawley rat blood.
| Raman Bands, cm−1 | Assignments | Observations | ||
|---|---|---|---|---|
| Leucine | Isoleucine | Diabetic Blood | ||
| 913 | 907 | - | C–C and C–N stretching in leucine and isoleucine | 1125, 1395, and 1585 cm−1 were considered peaks for diabetes type 2 [ |
| - | - | 926 | C–O and C–C stretch in glucose | |
| 1106 | 1108 | 1108 | C–C and C–N stretching in leucine and isoleucine; C–OH and C–O–H stretch in glucose | |
| - | - | 1125 | C–OH and C–O-H stretch in glucose | |
| 1236 | 1248 | 1248 | CH2 torsion in leucine and isoleucine | |
| 1302 | - | 1302 | CH deformation in leucine | |
| 1395 | - | 1395 | CH and CH3 bending; CH3 deformation in leucine | |
| - | 1437 | 1437 | Asymmetric rocking, symmetric bending of C atoms in isoleucine | |
| - | 1585 | 1585 | - | |
Typical FTIR band assignments of an adipose tissue.
| FTIR Bands, cm−1 | Assignment | Observations |
|---|---|---|
| 3290 | N–H (Amide A) and OH symmetric stretching | Proteins and small input of polysaccharides, carbohydrates and water [ |
| 3006 | CH stretching vibration | Unsaturated lipids, cholesterol esters [ |
| 2924, 2854 | CH2 anti-symmetric and symmetric stretching | Lipids with proteins, carbohydrates, nucleic acids effect [ |
| 1744 | Carbonyl C–O stretch | Triglycerides [ |
| 1654 | Amide I | Protein C–O stretching [ |
| 1547 | Amide II (C–N stretch, protein N–H bend) | Proteins [ |
| 1469 | CH2 bending | Acyl chains of lipids [ |
| 1375 | C–N stretching | [ |
| 1238 | Asymmetric PO2− stretching | [ |
| 1164 | C–O stretching | Found in normal tissue [ |
| 1100 | Stretching PO2− symmetric (phosphate II) | [ |
FTIR wavenumbers selected to classify the cervical lesions using GA-LDA/QDA model [124].
| FTIR Bands, cm−1 | Assignment | Observations | ||
|---|---|---|---|---|
| NILM vs. SIL | NILM vs. LSIL | NILM vs. HSIL | ||
| 1747 | - | 1758 | C=O stretching vibrations | Lipids |
| 1724 | 1724 | 1729 | C=O stretching vibrations | aldehydes |
| 1631 | - | 1639 | C=O stretching vibration; C-N bond stretching | Amide I group coupled with N–H bending |
| 1539 | - | 1531 | C–N stretching and N–H deformation | Amide II |
| - | 1334 | 1342 | Amide III | Proteins |
| 1454 | 1461 | 1467 | CH3 and CH2 deformations | Lipids and proteins |
| 1400 | - | - | CH3 | Lipids and proteins |
| - | 960 | 968 | C–H bending | |
| 1219 | 1221 | - | Asymmetric stretching vibrations of phosphate | |
| 1080 | 1089 | - | Symmetric stretching vibrations of phosphate | |
| 1155 | - | - | C–O | Carbohydrates |
| - | - | 1043 | OH stretching coupled with bending | Glycogen band |
| - | - | 1063 | CO–O–C symmetric stretching | Phospholipids and cholesterol esters |
The major bands assignments of an ectocervical cell.
| FTIR Bands, cm−1 | Assignment | Observations |
|---|---|---|
| 3000 − 2800 | C–H stretching of methyl/methylene | Lipids [ |
| 1735 | CO–O–C ester carbonyl stretching vibration | |
| 1665 *; 1650–1655 ** and 1635 *** | Amide I (C=O stretching) coupled with N–H in-plane bending | Peptide moiety (* random coil and β-turns; ** α-helical structures; *** β-pleated structures) [ |
| 1544 | C–N stretching and N–H in-plane bending | Amide II |
| 1400–1450 | C–H bending | Lipids and proteins |
| 1305 | Amide III | Proteins, aliphatic amino acids [ |
| 1244 * and 1225 ** | Asymmetric stretching vibrations of phosphate | Nucleic acid phosphodiester backbone (* α-DNA, ** β-DNA) [ |
| 1080 | Symmetric stretching vibrations of phosphate | Stronger hydrated tissues and cells [ |
| 1055, 1080, and 1150 | C–O stretching bands | Glycogen moiety |
The major bands assignments provided in GI cancers.
| Condition | FTIR Peak, cm−1 | Assignment | Observations | |
|---|---|---|---|---|
| Normal | Cancer | |||
| Oral cancer | 1030 | 1024 OLK or 1025 OSF | C−O Stretching Coupled with C−O bending | Superficial Layer rich in Glycogen [ |
| Colorectal cancer | 3256 | 3261 | N−H and OH stretching vibrations | Higher intensity of protein and water for malignant tissues [ |
| 1647 | 1641 | Amide I | Large amount of mucus for colon adenocarcinoma [ | |
| 1547 | 1544 | Amide II | ||
| 1093 | 1084 | PO2 group of nucleic acids | Endless replication of DNA in cancerous cells [ | |
| Gastric cancer | 1646 | 1641/1640/1642 | Amide I | (Malign/chronic atrophic/superficial gastritis) [ |
| 1553 | 1549/1547/1546 | Amide II | ||
| 1317 | 1313/1306/1316 | Amide III, symmetric stretch | ||
The main structural shifts observed in IR and Raman spectra of different skin lesions.
| Characteristic Bands, cm−1 | Assignments | Observations | ||
|---|---|---|---|---|
| FTIR | 2800–3000 | CH2 | Lipids; BCC tumour cells predominantly [ | |
| 1740 | Ester and acyl | Lipids; increased amount in BCC tumour cells [ | ||
| 1650 | Amide I | Proteins; variations of the amide I/amide II intensity ratio [ | ||
| 1480–1575 | Amide II | Proteins [ | ||
| 1235–1245 | Amide III | Proteins; the amide III and DNA spectral features are modified and enhanced with progression to malignancy [ | ||
| 980, 1080 and 1240 | Nucleic acids: ribose, phosphate | Increased intensity in all tumour types; most intense in BCC; 1080 cm−1 shoulder in MM and SCC [ | ||
| Raman | 1420-1450 | CH2 | Lipids in BCC (scissoring vibration) [ | |
| 1300 | –(CH2)n– | BCC (in-phase twist vibration) [ | ||
| NIR-FT Raman | 1661 | Amide I | Proteins; variations in intensity (MM, PN) [ | |
| 1451 | CH2 and CH3 | Proteins and lipids; wide signal for MM, BCC and SK [ | ||
| 1309 | CH2 | Lipids; increased intensity (MM, BCC, SK) [ | ||
| 1271 | Amide III | Proteins; Decreased intensity (BCC, SCC, SK) [ | ||
| 1247 | PO2− | Nucleic acids and phospholipids | Decrease in SK, BCC [ | |
| 1080 | Increase in SK, SCC [ | |||
| 939 | C–C | Proline and valine from proteins and lipids; decrease in BCC MM and SK [ | ||
Distribution of typical absorption bands acknowledged in brain tissues.
| Condition | Peak, cm−1 | Assignment | Observations |
|---|---|---|---|
| Normal mouse white matter | 2927, 1469 | CH2 | High concentration of long-chain fatty acids in myelin [ |
| 1740 | C=O | Lipid content | |
| 1550 | Amide II | Cerebrum | |
| 1235 | P=O | Phospholipids (25.2%) | |
| 1085 | OH–C–H | Galactose | |
| Krabbe’s disease | 2919 | CH2 | Psychosine accumulation [ |
| Normal mouse brain | 2956, 2922, 2871, 2851 | CH3, CH2 | Strong asymmetric and weak symmetric stretching [ |
| 1630, 1640/1658 and 1652 | Amide I | α-helical protein secondary structure in neuropil and neuron | |
| Alzheimer’s disease | 1623 | Amide I | Dense plaque cores of TgCRND8 mice; |
| 1080 and 1230 | C–H | Increased phospholipids | |
| Human grey matter-Normal | 1650–1656 | Amide I | α-helical conformation [ |
| 1542 | Amide II | ||
| Alzheimer’s disease | 1632-1634 | Amide I | β-amyloid structure [ |
| 1540 | Amide II | ||
| Normal human substantia nigra of brain | 3300, 3080 | N–H | Protein [ |
| 2960, 2930, 2850, 1460, 1380 | CH3, CH2 | Lipids | |
| 1656, 1633 | Amide I | Proteins with α-helical structures | |
| 1545 | Amide II | ||
| 1300 | Amide III | Proteins | |
| 1170 | CO–O–C | Lipids | |
| 1085 | PO2− | Nucleic aids | |
| Parkinson’s disease | 2930, 2850 | CH2 | Higher intensity [ |
| 1643, 1682, 1662 | Amide I | α-synuclein (β-sheet and β-turn band) [ | |
| 1236, 1086 | PO2− | Significant intensity decrease [ | |
| 1173 | –CO–O–C | Higher intensity [ | |
| Normal central nervous system | 1735 | C=O | Lipids and fatty acids [ |
| 1690, 1650, 1635 | Amide I | β-sheet and α-helix protein secondary structure [ | |
| 1560 | C–N | Proteins [ | |
| 1235, 1080 | PO2− | Phosphodiester and nucleic acids backbone (RNA and DNA) [ | |
| 965 | P–O–C | Nucleic acids (DNA and RNA) [ | |
| Multiple sclerosis | 1690, 1635 | Amide I | Controlled by anti-parallel β-pleated and β-pleated sheet constituents [ |
| Normal human cerebrospinal fluid | 3010 | C=CH | Unsaturated lipids [ |
| 2920 and 2850 | CH2 | Long hydrocarbon chains in lipids [ | |
| 1730 | C=O | Proteins [ | |
| 1657 | Amide I | ||
| 1546 | Amide II | Lipids [ | |
| CIS, TCIS, RRMS | 1732 | C=O | Significant increase in carbonyl amount [ |
| 795 | Guanine C3′-endo/syn conformation in the Z-DNA [ | ||